Nutraplus India reports net loss of ₹35.86 lakh in Q2FY25
Nutraplus India Limited reported a net loss of ₹35.86 lakh for Q2FY25 with zero revenue, following the loss of all assets under the SARFEASI Act. Auditors qualified their report due to compliance delays and late information submission. Total expenditure for the quarter was ₹45.14 lakh, while negative equity stood at ₹571.52 lakh.

*this image is generated using AI for illustrative purposes only.
Nutraplus India Limited reported a net loss of ₹35.86 lakh for the quarter ended September 30, 2025, as operations remain stalled with zero revenue. The company disclosed that it lost all property, plant, and equipment under the SARFEASI Act, 2002, after being declared a Non-Performing Asset in FY-2019-20, with auction procedures delayed due to COVID-19.
The Board of Directors approved the unaudited standalone financial results for the quarter and half-year ended September 30, 2025, on October 25, 2025. Raman S. Shah & Associates, Chartered Accountants, issued a qualified limited review report, citing the company's failure to comply with listing requirements under the Companies Act, 2013, and SEBI regulations. The auditor noted that significant delays in providing necessary financial data impaired their ability to perform a comprehensive review.
Total expenditure for the quarter stood at ₹45.14 lakh, primarily driven by other expenditure, while finance costs amounted to ₹0.36 lakh. For the half-year period, the net loss widened to ₹36.51 lakh. The company's equity position remains negative at ₹-571.52 lakh as of September 30, 2025, compared to ₹-535.02 lakh as of March 31, 2025.
Financial Performance Summary
| Metric | Q2FY25 (₹ in Lacs) | Q2FY24 (₹ in Lacs) | H1FY25 (₹ in Lacs) | H1FY24 (₹ in Lacs) |
|---|---|---|---|---|
| Total Income | 9.67 | - | 9.67 | - |
| Total Expenditures | 45.14 | 0.09 | 45.41 | 0.12 |
| Net Profit/(Loss) | (35.86) | (0.47) | (36.51) | (0.86) |
| Earnings Per Share | (0.11) | (0.00) | (0.11) | (0.00) |
Assets and Liabilities
The company's balance sheet reflects the impact of its operational halt. Total assets decreased to ₹499.76 lakh as of September 30, 2025, from ₹516.22 lakh as of March 31, 2025. Non-current liabilities, primarily borrowings, increased to ₹222.74 lakh from ₹178.54 lakh over the same period. Current liabilities stood at ₹848.53 lakh, largely comprising trade payables of ₹845.17 lakh.
Cash flow from operating activities for the half-year ended September 30, 2025, was negative at ₹44.55 lakh. However, financing activities provided a net inflow of ₹44.16 lakh, resulting in a marginal net decrease in cash and cash equivalents of ₹0.39 lakh, bringing the closing balance to ₹6.41 lakh.
Does Nutraplus India have a viable strategy to resume operations given the total loss of property, plant, and equipment?
What are the potential regulatory consequences for the company's failure to comply with SEBI listing requirements?
How does the company plan to address the widening negative equity position and mounting trade payables?




























